Tim Fagan's Law
Latest action · May 23, 2005 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 12, 2005
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and Human Services within 48 hours after first receiving or becoming aware of information that reasonably suggests that such a violation may have occurred.
Deems a drug to be misbranded if it is not manufactured in accordance with the use of technologies that the Secretary determines are technically feasible and will assist in preventing such violations.
Requires the Secretary to establish alternative requirements to the extent that such requirements provide greater certainty on the chain of custody and are technically feasible.
Increases funding for Food and Drug Administration (FDA) inspections, examinations, and investigations.
Requires the Secretary to educate the public and health care professionals on counterfeit drugs.
Directs the Secretary: (1) upon a finding of reasonable probability that a drug intended for human use would cause serious health consequences or death, to issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the drug) to cease distribution of the drug and to notify and instruct health professionals to cease administering or prescribing the drug; and (2) amend the order to include a recall if necessary.
Cosponsors 14
Members who signed on, in the order they did. Signatures ran from Dec 13, 2005 to Jul 26, 2006.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-IL | Danny K. Davis | Dec 13, 2005 | |
| D-CA | Diane E. Watson | Dec 13, 2005 | |
| D-DC | Eleanor Holmes Norton | Dec 13, 2005 | |
| D-MD | Elijah E. Cummings | Dec 13, 2005 | |
| D-NY | Gary L. Ackerman | Dec 13, 2005 | |
| D-NY | Major R. Owens | Dec 13, 2005 | |
| D-TX | Sheila Jackson Lee | Dec 13, 2005 | |
| D-NY | Brian Higgins | Dec 14, 2005 | |
| D-AZ | Ed Pastor | Dec 22, 2005 | |
| D-CA | Henry A. Waxman | Dec 22, 2005 | |
| D-PA | Chaka Fattah | Feb 14, 2006 | |
| D-CA | Lynn C. Woolsey | Feb 14, 2006 | |
| D-MI | John Conyers, Jr. | Mar 2, 2006 | |
| D-NY | Nita M. Lowey | Jul 26, 2006 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 12, 2005 |
| Health Subcommittee | Referred May 23, 2005 |
Actions 4
Everything that happened, newest first.
- May 23, 2005Referred to the Subcommittee on Health.
- May 12, 2005Introduced in House
- May 12, 2005Sponsor introductory remarks on measure. (CR E950-951)
- May 12, 2005Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Extensions | Debate and remarks E950 | Steve Israel D-NY | May 12, 2005 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 109-194 | SICK CRIME: COUNTERFEIT DRUGS IN THE UNITED STATES158 pages | Oversight and Government Reform Committee | Nov 1, 2005 |
| S. Hrg. 109-91 | FEDERAL RECOGNITION294 pages | Indian Affairs Committee | May 11, 2005 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1396 | Counterfeit Drug Enforcement Act | Related bill | Mar 22, 2005 |
| S 1978 | Tim Fagan's Law | Related bill | Nov 9, 2005 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes.
- Short Titles as Introduced
- Tim Fagan's Law
- Counterfeit Drug Enforcement Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative procedure
- Administrative remedies
- Business records
- Commerce
- Communication in medicine
- Consumer protection
- Crime and Law Enforcement
- Criminal investigation
- Criminal justice information
- Deceptive advertising
- Defective products
- Department of Health and Human Services
- Directories
- Drug adulteration
- Drug industry
- Drugs
- Fines (Penalties)
- Food and Drug Administration (FDA)
- Government Operations and Politics
- Government paperwork
- Government publicity
- Governmental investigations
- Health
- Health education
- Identification devices
- Informers
- Intellectual property
- Labeling
- Law
- Medical personnel
- Packaging
- Product counterfeiting
- Science, Technology, Communications
- Subpoena
- Wholesale trade
Text 1
Each version as it was printed, newest first.
- May 12, 2005Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.